After initiation of insulin therapy in T1D the lowering of blood glucose levels and insulin demand leads to decreased ER stress and increased insulin production in the remaining beta cells known as the “honeymoon” period in T1D (Clark and Urano, 2016). This evidence concerns the gene INS and type 1 diabetes mellitus.